For the Sereno family, time has always been important. And for Lina Sereno, trusting her gut made all of the difference when it came […]
From recommendation to reality: Why newborn screening needs funding now Read More »
A new seven-point plan to strengthen America’s biotechnology leadership amid intensifying global competition from China was released by the Biotechnology Innovation Organization (BIO) on
BioAdvance: BIO releases national action plan to strengthen US biotech leadership Read More »
The most dangerous antimicrobial-resistant (AMR) pathogens in America are causing an estimated 9.7 million infections and 50,800 deaths in the U.S. each year, says
CDC report details impact of AMR pathogens Read More »
The Tigerlily Foundation was born from a promise made in a moment of profound vulnerability. In 2006, Maimah Karmo was a 32-year-old mother to
Tigerlily Foundation joining conversation at PACE Read More »
BIO’s comments advise strengthening communication and clarity of recommendations, and maintaining access. The Advisory Committee on Immunization Practices (ACIP) should remain the body responsible
BIO supports retaining current vaccine recommendation categories Read More »
The SBIR and STTR federal seed funding programs—essential to many biotech start-ups—have been updated with important changes that provide new opportunities to applicants. These
National Cancer Institute explainer for CSBA: Why and how to apply for SBIR Read More »
BIO 2026 Start-Up Stadium winner generates human data to improve clinical translation. Artificial intelligence is opening new possibilities for drug discovery. But in neuroscience,
BrainStorm Therapeutics combines brain organoids and AI for CNS drug discovery Read More »
Stronger intellectual property protection statistically correlates with increased development of cutting-edge therapies and greater investment in life sciences research, according to a closely watched
Strong IP ecosystems drive biotech R&D and investment, report shows Read More »
A Food and Drug Administration (FDA) pilot program to expedite approval of new drugs contains potentially impactful initiatives but risks adding burdens, says the
BIO applauds efforts targeting early drug development efficiency, provides suggestions Read More »
Biotech innovation provides better-than-average salaries and pumps hundreds of billions of dollars into the U.S. economy annually—and the societal benefits of this innovation can
Studies show value of biotech IP for the economy and society Read More »
